Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05776875
Title Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yale University
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.